Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2024-05-15 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于公司产品获得IVDR CE认证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the certification of 11 medical device products obtaining IVDR CE certification. It includes product details, certification validity, and regulatory context about the EU IVDR regulation. The document is short (1572 characters) and does not contain any financial data, financial statements, or detailed financial analysis. It is an announcement about a regulatory certification achievement rather than a financial report or management discussion. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a regulatory filing about compliance or officer certification. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into other specific categories.
2024-05-15 Chinese
2023年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2023 annual dividend distribution plan approved at the 2023 Annual General Meeting. It details the dividend amount per share, the record date, the ex-dividend date, and the method of dividend payment. It also references the shareholder meeting resolutions and related documents. The document is relatively short (2075 characters) and serves as a formal notice of the dividend distribution rather than the full annual report or financial statements. Therefore, it fits the category of a Notice of Dividend Amount (DIV).
2024-05-13 Chinese
关于减少注册资本暨债权人通知的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Dirui Medical Technology Co., Ltd. regarding the reduction of registered capital and notification to creditors. It details the board resolutions about repurchasing and canceling restricted shares, the resulting decrease in total shares and registered capital, amendments to the company articles of association, and creditor notification procedures. The document does not contain financial statements or detailed financial performance data but is a formal disclosure about capital reduction and related corporate actions. It is not a full annual or interim report, nor an earnings release or management discussion. It is also not a proxy statement or voting result announcement. The document fits best as a Regulatory Filing (RNS) because it is a regulatory announcement about corporate capital changes and creditor notification without substantive financial data or report content.
2024-05-10 Chinese
2023年年度股东大会法律意见
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2023 Annual General Meeting (AGM) of a company. It details the procedures of the AGM, including the convening, attendance, voting procedures, and results of various resolutions. The document does not contain financial statements or management discussion but focuses on the legality and validity of the AGM process and voting outcomes. It is not the annual report itself, nor an earnings release or management report. It is not a proxy statement or remuneration report. The document is a legal opinion related to the AGM, which is typically classified as AGM Information (AGM-R). The document length is over 6,000 characters and contains detailed AGM-related content, not just an announcement or certification, so it is not RPA or RNS. Therefore, the best classification is AGM Information (AGM-R).
2024-05-10 Chinese
2023年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2023 Annual General Meeting (AGM) of the company, including voting results on various proposals such as the board report, financial report, profit distribution, amendments to the articles of association, and election of supervisors. It includes specifics on meeting attendance, voting methods, and legal opinions on the meeting's validity. The document does not contain the full annual report or financial statements themselves but reports on the voting outcomes and decisions made at the AGM. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and content confirm it is not a brief report publication announcement or a full annual report. Therefore, the correct classification is DVA with high confidence.
2024-05-10 Chinese
2023年年度报告
Annual Report Classification · 100% confidence The document is titled "迪瑞医疗科技股份有限公司2023 年年度报告全文" which translates to "Dirui Medical Technology Co., Ltd. 2023 Annual Report Full Text." It contains detailed sections including company overview, financial data, management discussion and analysis, governance, environmental and social responsibility, important matters, shareholder information, bond information, and a full financial report section. The document includes comprehensive financial figures, management analysis, accounting policy changes, and detailed business descriptions. The length is substantial (15,000 characters), and it is clearly the full annual report for the fiscal year 2023. There is no indication that this is merely an announcement or a summary; it contains the full report content. Therefore, the document fits the definition of an Annual Report (10-K). FY 2023
2024-04-18 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.